meperidine has been researched along with n,n-dimethyl-3,3-diphenyl-1-methylallylamine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kjaer, M; Nielsen, H | 1 |
Breivik, H; Raeder, JC; van der Linden, J | 1 |
Grosman, N | 1 |
Anderson, P; Arnér, S; Bondesson, U; Boréus, LO; Hartvig, P | 1 |
Christensen, CB; Christrup, LL; Kristensen, K; Nielsen, LC | 1 |
Andersen, S; Ebert, B; Thorkildsen, C | 1 |
1 trial(s) available for meperidine and n,n-dimethyl-3,3-diphenyl-1-methylallylamine
Article | Year |
---|---|
Premedication for day-case surgery: double-blind comparison of ketobemidone + dimethylaminodiphenylbuten (A-29) and morphine + scopolamine.
Topics: Abortion, Legal; Adolescent; Adult; Allylamine; Ambulatory Surgical Procedures; Amines; Anesthesia, General; Dilatation and Curettage; Drug Therapy, Combination; Female; Humans; Meperidine; Middle Aged; Morphine; Nitrous Oxide; Preanesthetic Medication; Pregnancy; Scopolamine; Thiopental | 1986 |
5 other study(ies) available for meperidine and n,n-dimethyl-3,3-diphenyl-1-methylallylamine
Article | Year |
---|---|
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets | 1988 |
Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29.
Topics: Allylamine; Analgesics, Opioid; Animals; Basophils; Butylamines; Histamine Release; Humans; In Vitro Techniques; Mast Cells; Meperidine; Morphine; Parasympatholytics; Rats; Rats, Inbred Strains | 1982 |
Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.
Topics: Adult; Allylamine; Biological Availability; Humans; Injections, Intravenous; Kinetics; Male; Meperidine; Parasympatholytics; Rectum; Suppositories | 1981 |
The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene.
Topics: Allylamine; Analgesics, Opioid; Animals; Binding, Competitive; Cattle; Caudate Nucleus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Humans; Isonipecotic Acids; Meperidine; Parasympatholytics; Phenols; Receptors, Opioid, delta; Receptors, Opioid, mu | 1996 |
Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist.
Topics: Allylamine; Analgesics, Opioid; Animals; Cerebral Cortex; Excitatory Amino Acid Antagonists; Membrane Potentials; Meperidine; Rats; Receptors, N-Methyl-D-Aspartate | 1998 |